Evidence map›Paper›PMID 27322081›Full record

ArticleOncotarget2016

Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.

Jinhoi Song, Jaemin Lee, Jinsil Kim, Seongyea Jo, Yeon Jeong Kim, Ji Eun Baek, Eun-Soo Kwon, Kwang-Pyo Lee, Siyoung Yang, Ki-Sun Kwon and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Jun, an Oncological Foe or Friend?International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Jinhoi SongAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Jaemin LeeAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Jinsil KimAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Seongyea JoAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Yeon Jeong KimDepartment of Biological Sciences, Dong-A University, Busan, Republic of Korea.
Ji Eun BaekDepartment of Biological Sciences, Dong-A University, Busan, Republic of Korea.
Eun-Soo KwonAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Kwang-Pyo LeeAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Siyoung YangAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Ki-Sun KwonAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Dong-Uk KimAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Tae Heung KangDepartment of Immunology, School of Medicine, Konkuk University, Seoul, Republic of Korea.
Yun-Yong ParkDepartment of Biomedical Sciences and Physiology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Suhwan ChangDepartments of Biomedical Sciences and Physiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hee Jun ChoImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Song Cheol KimDepartment of Surgery, University of Ulsan College of Medicine & Asan Medical Center, Seoul, Republic of Korea.
Sang Seok KohDepartment of Biological Sciences, Dong-A University, Busan, Republic of Korea.
Seokho KimAging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Korea Research Institute of Bioscience and Biotechnology · KRDong-A University · KRAsan Medical Center · KRKonkuk University · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is characterized by an immunosuppressive tumor microenvironment (TME) with a profound immune infiltrate populated by a significant number of myeloid-derived suppressor cells (MDSCs). MDSCs have been increasingly recognized for their role in immune evasion and cancer progression as well as their potential as a target for immunotherapy. However, not much is known about the mechanisms regulating their behavior and function in the pancreatic TME. Here we report that pancreatic adenocarcinoma up-regulated factor (PAUF), a soluble protein involved in pancreatic tumorigenesis and metastasis, plays a role as an enhancer of tumor-infiltrating MDSC and its functional activity. We show that PAUF enhanced the accumulation of MDSCs in the spleen and tumor tissues of PAUF-overexpressing tumor cell-injected mice. In addition, PAUF was found to enhance the immunosuppressive function of MDSCs via the TLR4-mediated signaling pathway, which was demonstrated by PAUF-induced increased levels of arginase, nitric oxide (NO), and reactive oxygen species (ROS). The role of PAUF in modulating the functional properties of MDSCs was further demonstrated by the use of a PAUF-neutralizing antibody that caused a decreased number of tumor-infiltrating MDSCs and reduced MDSC immunosuppressive activity. The observations made in mice were confirmed in human pancreatic cancer patient-derived MDSCs, supporting the clinical relevance of our findings. Collectively, we conclude that the PAUF is a powerful and multifunctional promoter of tumor growth through increase and functional activation of MDSCs, suggesting therapeutic potential for targeting PAUF in pancreatic cancers.

Indexed as

AnimalsCarcinoma, Pancreatic DuctalCell Line, TumorHumansIntercellular Signaling Peptides and ProteinsLectinsMembrane ProteinsMiceMyeloid-Derived Suppressor CellsPancreatic NeoplasmsTumor EscapeTumor MicroenvironmentIntercellular Signaling Peptides and ProteinsLectinsMembrane ProteinsZG16B protein, humanZG-16 protein, mouseMDSCpancreatic cancerPAUFtumor microenvironment

Identifiers

PMID27322081
PMCPMC5239518
OpenAlexW2433880588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.